本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apellis Pharmaceuticals Inc.

16.97
-0.6700-3.80%
盤後16.970.00000.00%16:37 EDT
成交量:176.27萬
成交額:3,015.48萬
市值:21.69億
市盈率:98.43
高:17.61
開:17.55
低:16.97
收:17.64
52周最高:30.48
52周最低:16.10
股本:1.28億
流通股本:7,811.99萬
量比:0.60
換手率:2.26%
股息:- -
股息率:- -
每股收益(TTM):0.1724
每股收益(LYR):0.1724
淨資產收益率:7.48%
總資產收益率:3.53%
市淨率:5.86
市盈率(LYR):98.43

資料載入中...

2024/12/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/22

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/22

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/05

重要事件披露

Form 8-K - Current report
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities